Palvella Therapeutics (PVLA) Tax Rate (2014 - 2025)
Palvella Therapeutics (PVLA) posted quarterly Tax Rate of 1.38% for Q4 2018, down 50.0% year-over-year from 2.77% in Q4 2017, and down 96.72% quarter-over-quarter from 42.17% in Q2 2018.
Palvella Therapeutics (PVLA) Tax Rate (2014 - 2025) Analysis & Trends
Palvella Therapeutics (PVLA) has reported Tax Rate for 4 consecutive years, with 1.38% the latest figure, recorded in Q4 2018.
- In Q4 2018, Tax Rate fell 50.0% year-over-year to 1.38%; the TTM figure through Sep 2019 stood at 0.45% (up 40.0% YoY), while the FY2020 annual figure was 0.44%, changed N/A from the prior year.
- Tax Rate fell to 1.38% in Q4 2018 per PVLA's latest filing, from 42.17% in the prior quarter.
- Across five years, Tax Rate topped out at 42.17% in Q2 2018 and bottomed at 8.78% in Q2 2017.
- Historically, Tax Rate has averaged 2.75% across 4 years, with a median of 0.0% in 2014.
- Annual changes were most pronounced in 2015 — Tax Rate slumped 104 bps — and 2018, when it jumped 5095 bps.
- Palvella Therapeutics' Tax Rate stood at 0.0% in 2014, then sank by 1884651 bps to 5.97% in 2015, then jumped by 132 bps to 1.89% in 2017, then declined by 27 bps to 1.38% in 2018.
- Business Quant data shows PVLA's Tax Rate at 1.38% in Q4 2018, 42.17% in Q2 2018, and 1.89% in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 68.56% |
| Dec 31, 2025 | 68.56% |
| Dec 31, 2025 | 68.56% |
| Dec 31, 2024 | 92.66% |
| Dec 31, 2024 | 92.66% |
| Dec 31, 2024 | 92.66% |
| Dec 31, 2018 | 1.38% |
| Dec 31, 2018 | 1.38% |
| Dec 31, 2018 | 1.38% |
| Jun 30, 2018 | 42.17% |
| Jun 30, 2018 | 42.17% |
| Jun 30, 2018 | 42.17% |
| Dec 31, 2017 | 1.89% |
| Dec 31, 2017 | 1.89% |
| Dec 31, 2017 | 1.89% |
| Sep 30, 2017 | -2.11% |
| Sep 30, 2017 | -2.11% |
| Sep 30, 2017 | -2.11% |
| Jun 30, 2017 | -8.78% |
| Jun 30, 2017 | -8.78% |